Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Latest filing alerts

Every SEC filing alert our engine sent, newest first: 8-K material events, deals, capital raises, leadership changes, results and insider buying and selling.

4:33 PM ET 8-K
Loan & Debt Cognizant Technology Solutions Corp CTSH

Cognizant Technology Solutions $2.4B Debt Financing with JPMorgan Chase Bank, N.A.

Cognizant entered into a new $2.4 billion unsecured credit agreement consisting of a $550 million term loan and a $1.85 billion revolving credit facility maturing in October 2031. The proceeds were primarily used to refinance and repay the company's existing credit facilities, with the revolving facility remaining available for general corporate purposes.

Value
$2.4B
Counterparty
JPMorgan Chase Bank, N.A.
Term
through Oct 2031
4:33 PM ET Form 4
Insider Buying Hormel Foods Corp HRL

Hormel Foods Insider William A. Newlands Buys $201K of Stock

William A. Newlands bought 10,000 shares of Hormel Foods Corp at $20.10 a share, worth $201K in total on Oct 5, 2026. Shares held after the trade: 76,375 (+15.1%).

Value
$201K
Shares
10,000
Price
$20.10
Holding change
+15.1%
Trade date
Oct 5, 2026
4:32 PM ET Form 4
Insider Selling United Therapeutics Corp UTHR

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells $5.15M of Stock

Martine A. Rothblatt, Chairperson & CEO, sold 9,500 shares of United Therapeutics Corp at $536.26 to $546.63 a share (average $541.64) in 11 transactions, worth $5.15M in total on Oct 5, 2026. Shares held after the trade: 325,723 (-0.4%).

Value
$5.15M
Shares
9,500
Average price
$541.64
Role
Chairperson & CEO
Holding change
-0.4%
Trade date
Oct 5, 2026
4:32 PM ET 8-K
Reverse Stock Split Vivakor, Inc. VIVK

Vivakor Reverse Stock Split

Vivakor, Inc. implemented a 1-for-15 reverse stock split of its common stock, effective October 5, 2026. The action is intended to increase the per-share trading price to regain compliance with Nasdaq's minimum bid price requirement for continued listing. This follows a previous 1-for-20 reverse split that was effective in July 2026.

4:32 PM ET 8-K
Executive Compensation Aviat Networks, Inc. AVNW

Aviat Networks Executive Compensation

Aviat Networks, Inc. appointed Khashayar “Hash” Pakbaz as Senior Vice President and Chief Operations Officer, effective October 5, 2026. His employment agreement includes an annual base salary of $365,000, a target annual bonus of 50% of base salary, and a one-time restricted stock unit award valued at $200,000 with a two-year vesting period.

Term
1 year
4:31 PM ET Form 4
Insider Selling Elastic N.V. ESTC

Elastic Chief Revenue Officer Mark Eugene Dodds Sells $926K of Stock

Mark Eugene Dodds, Chief Revenue Officer, sold 10,000 shares of Elastic N.V. at $92.58 a share, worth $926K in total on Oct 2, 2026. Shares held after the trade: 278,538 (-3.5%).

Value
$926K
Shares
10,000
Price
$92.58
Role
Chief Revenue Officer
Holding change
-3.5%
Trade date
Oct 2, 2026
4:31 PM ET 8-K
M&A Deal Melar Acquisition Corp. I MACI

Melar Acquisition Corp. I M&A Deal with Everli Global Inc.

Melar Acquisition Corp. I announced that the SEC has declared effective its registration statement on Form S-4 for its proposed business combination with Everli Global Inc., an Italian e-grocery marketplace. The company has scheduled an extraordinary general meeting for October 22, 2026, to vote on the merger, which is expected to result in the combined entity trading on Nasdaq under the ticker 'EVRL'.

Counterparty
Everli Global Inc.
4:31 PM ET 8-K
Leadership Change Quest Diagnostics Inc DGX

Quest Diagnostics Leadership Change

Quest Diagnostics announced that Catherine T. Doherty will retire in July 2027, transitioning to a new role as Executive Vice President effective November 1, 2026. In her new role, she will oversee health systems, a joint venture with Corewell Health, and the Project Nova modernization initiative while maintaining her current base salary and receiving a $1.2 million RSU grant.

Term
through July 2027
4:31 PM ET 8-K
Leadership Change Walker & Dunlop, Inc. WD

Walker & Dunlop Leadership Change

Stephen P. Theobald, Executive Vice President and Chief Operating Officer, notified the company of his intention to retire effective March 31, 2027. His responsibilities will be divided among other employees, and the company stated his departure is not due to any disagreement regarding operations, policies, or practices.

4:31 PM ET Form 4
Insider Selling Elastic N.V. ESTC

Elastic Insider Steven Schuurman Sells $135M of Stock

Steven Schuurman sold 1,500,000 shares of Elastic N.V. at $90.13 a share, worth $135M in total on Oct 5, 2026. Shares held after the trade: 4,504,600 (-25.0%).

Value
$135M
Shares
1,500,000
Price
$90.13
Holding change
-25.0%
Trade date
Oct 5, 2026
4:31 PM ET 8-K
Executive Compensation Powerus Corp PUSA

Powerus Executive Compensation

Powerus Corporation appointed Colin Chisholm as Chief Operating Officer, effective October 12, 2026. Chisholm's compensation package includes an initial base salary of $325,000, a target annual incentive award of 30-40%, and a grant of 300,000 restricted stock units vesting over four years.

Counterparty
Colin Chisholm
Term
2 years
4:30 PM ET 8-K
Divestiture BeyondSpring Inc. BYSI

BeyondSpring Divestiture to Biolin Investment Limited

BeyondSpring Inc. completed the sale of its entire issued share capital in BeyondSpring Ltd. to Biolin Investment Limited, effectively divesting its interests in Dalian Wanchunbulin Pharmaceuticals and SEED Therapeutics. The transaction was for non-cash consideration, consisting of a strategic collaboration where the investor funds and completes the China portion of the DUBLIN-4 Phase 3 clinical trial. BeyondSpring retains rights to the clinical data generated from the trial and a potential equity clawback if enrollment targets are not met.

Counterparty
Biolin Investment Limited
Term
3 years
4:30 PM ET 8-K
Nasdaq/NYSE Compliance Notice Virtuix Holdings Inc. VTIX

Virtuix Holdings Nasdaq/NYSE Compliance Notice

Virtuix Holdings Inc. received a deficiency notice from Nasdaq on September 30, 2026, for failing to maintain a minimum market value of listed securities (MVLS) of $50 million. The company has 180 calendar days, or until March 29, 2027, to regain compliance by maintaining a $50 million MVLS for at least ten consecutive business days. Virtuix is monitoring its options, which may include transferring its listing to The Nasdaq Capital Market.

Counterparty
Nasdaq
Term
180 days
4:30 PM ET 8-K
Other 8-K Filing Sonoma Pharmaceuticals, Inc. SNOA

Sonoma Pharmaceuticals Other 8-K Filing

Sonoma Pharmaceuticals adopted a Section 382 Rights Agreement (poison pill) to protect its net operating loss carryforwards (NOLs) from being limited by an 'ownership change'. The agreement issues one preferred stock purchase right for each share of common stock, intended to deter any person or group from acquiring 5% or more of the company's shares.

Counterparty
Computershare Inc.
4:30 PM ET 8-K
Regulatory Approval HeartSciences Inc. HSCS

HeartSciences Regulatory Approval

HeartSciences received FDA 510(k) clearance for its MyoVista wavECG device as a 12-lead resting electrocardiograph for adult and pediatric patients. While the company does not intend to commercialize the device without a cleared AI-ECG algorithm, the approval broadens strategic options for the asset and its intellectual property. The company also noted its pending merger with Fortitude Mining Holdings remains on track to close in Q4 2026.

4:30 PM ET Form 4
Insider Buying Keenova Therapeutics plc

Keenova Therapeutics Insider Goldentree Asset Management LP Buys $42.1M of Stock

Goldentree Asset Management LP bought 463,000 shares of Keenova Therapeutics plc at $91.00 a share, worth $42.1M in total on Sep 24, 2026. Shares held after the trade: 8,442,827 (+5.8%).

Value
$42.1M
Shares
463,000
Price
$91.00
Holding change
+5.8%
Trade date
Sep 24, 2026
4:30 PM ET Form 4
Insider Buying QVC Group, Inc. QVCG

QVC Group Insider Goldentree Asset Management LP Buys $3.46M of Stock

Goldentree Asset Management LP bought 250,000 shares of QVC Group, Inc. at $13.85 a share, worth $3.46M in total on Oct 2, 2026. Shares held after the trade: 11,327,754 (+2.3%).

Value
$3.46M
Shares
250,000
Price
$13.85
Holding change
+2.3%
Trade date
Oct 2, 2026
4:30 PM ET Form 4
Insider Selling NetApp, Inc. NTAP

NetApp Director Carrie Palin Sells $1.08M of Stock

Carrie Palin, Director, sold 5,000 shares of NetApp, Inc. at $216.43 a share, worth $1.08M in total on Oct 2, 2026. Shares held after the trade: 6,660 (-42.9%).

Value
$1.08M
Shares
5,000
Price
$216.43
Role
Director
Holding change
-42.9%
Trade date
Oct 2, 2026
4:30 PM ET Form 4
Insider Selling World Kinect Corp WKC

World Kinect Executive Chairman Michael J. Kasbar Sells $357K of Stock

Michael J. Kasbar, Executive Chairman, sold 10,000 shares of World Kinect Corp at $35.67 a share, worth $357K in total on Oct 2, 2026. Shares held after the trade: 956,450 (-1.0%).

Value
$357K
Shares
10,000
Price
$35.67
Role
Executive Chairman
Holding change
-1.0%
Trade date
Oct 2, 2026
4:30 PM ET Form 4
Insider Buying Corebridge Financial, Inc. CRBG

Corebridge Financial 10% Owner Nippon Life Insurance Co Buys $6.41M of Stock

Nippon Life Insurance Co, 10% Owner, bought 187,155 shares of Corebridge Financial, Inc. at $34.27 a share, worth $6.41M in total on Oct 2, 2026. Shares held after the trade: 126,604,050 (+0.1%).

Value
$6.41M
Shares
187,155
Price
$34.27
Role
10% Owner
Holding change
+0.1%
Trade date
Oct 2, 2026
4:30 PM ET 8-K
Divestiture Clarivate PLC CLVT

Clarivate Divestiture to Altaris, LLC for $600M

Clarivate Plc completed the sale of its Life Sciences and Healthcare business to an affiliate of Altaris, LLC for total consideration of $600 million. The deal consists of $500 million in cash, a $75 million unsecured senior note, and $25 million in deferred cash consideration. The divestiture is intended to sharpen the company's focus on its Academia & Government and Intellectual Property segments while using proceeds to reduce debt.

Value
$600M
Counterparty
Altaris, LLC
4:29 PM ET 8-K
Dividend Cantor Fitzgerald Income Trust, Inc. CFTR-PA

Cantor Fitzgerald Income Trust Dividend

Cantor Fitzgerald Income Trust, Inc. declared monthly cash distributions for September 2026 across all classes of its common stock and operating partnership units. The distributions, calculated as 5.00% of NAV on an annual basis, are payable to stockholders of record as of September 30, 2026, and will be paid on or about October 6, 2026.

4:27 PM ET 8-K
Financial Results Penguin Solutions, Inc. PENG

Penguin Solutions Financial Results

Penguin Solutions reported record fiscal fourth quarter and full year 2026 results, with Q4 net sales growing 68% year-over-year to $567 million. The performance was driven by significant acceleration in AI-driven data center demand and the launch of the company's AI Factory Platform. Based on this momentum, the company raised its fiscal 2027 outlook for both net sales and non-GAAP diluted EPS.

Term
FY2026
Earnings call
Oct 6, 2026, 4:30 PM ET

“Our company performance accelerated significantly in the second half of fiscal 2026 following the launch of our AI Factory Platform and increased focus on the data center market. We prioritized and aligned our AI Infrastructure and Memory businesses with strong AI-driven data center demand, increased investment in product innovation, and sharpened go-to-market execution with a focus on making neocloud and enterprise customers successful.”

Kash Shaikh, president and CEO of Penguin Solutions

“The proof is in the results. After relatively flat year-over-year net sales in the first half, growth accelerated to 48% in Q3 and 68% in Q4, driving second-half growth of 58%. As we enter fiscal 2027, our memory business remains strong, and our AI Infrastructure business is accelerating further.”

Kash Shaikh, president and CEO of Penguin Solutions
4:27 PM ET 8-K
Leadership Change Slb Limited SLB

Slb Leadership Change

SLB Limited appointed Ms. Jing Ulrich to its Board of Directors, effective October 5, 2026. Ms. Ulrich, a former Vice Chairman of Investment Banking at JPMorgan Chase & Co., will also serve on the Board's Audit and Finance Committees. She will serve as a director until the company's next annual general meeting, where she will be subject to re-election.

Counterparty
Jing Ulrich
4:25 PM ET Form 4
Insider Selling Roblox Corp RBLX

Roblox Chief Legal Off. & Corp. Sec. Mark Reinstra Sells $250K of Stock

Mark Reinstra, Chief Legal Off. & Corp. Sec., sold 5,666 shares of Roblox Corp at $43.88 to $44.56 a share (average $44.20) in 2 transactions, worth $250K in total on Oct 5, 2026. Shares held after the trade: 386,625 (-0.7%).

Value
$250K
Shares
5,666
Average price
$44.20
Role
Chief Legal Off. & Corp. Sec.
Holding change
-0.7%
Trade date
Oct 5, 2026
4:25 PM ET Form 4
Insider Selling Cytokinetics Inc CYTK

Cytokinetics EVP Research & Development Fady Ibraham Malik Sells $215K of Stock

Fady Ibraham Malik, EVP Research & Development, sold 3,500 shares of Cytokinetics Inc at $61.38 a share, worth $215K in total on Oct 6, 2026. Shares held after the trade: 153,902 (-2.2%).

Value
$215K
Shares
3,500
Price
$61.38
Role
EVP Research & Development
Holding change
-2.2%
Trade date
Oct 6, 2026
4:23 PM ET 8-K
Other 8-K Filing FingerMotion, Inc. FNGR

FingerMotion Other 8-K Filing

FingerMotion, Inc. held a special meeting of stockholders on October 6, 2026, where shareholders approved two key proposals. The first proposal approved a share issuance under Nasdaq Rule 5635(d), and the second proposal authorized an increase in the company's total authorized shares to 500 million.

4:23 PM ET 8-K
Business Update Biomarin Pharmaceutical Inc BMRN

Biomarin Pharmaceutical Business Update

BioMarin disclosed the estimated financial impact of its August 31, 2026, acquisition of Alesta Therapeutics, including a $283 million pre-tax charge for acquired in-process research and development (IPR&D). The acquisition is expected to have a $1.50 unfavorable impact on Q3 2026 EPS and a $1.55 impact on full-year 2026 EPS, with updated full-year guidance to be provided during the Q3 earnings call.

Counterparty
Alesta Therapeutics B.V.
4:22 PM ET Form 4
Insider Selling Procter & Gamble Co PG

Procter & Gamble CFO Andre Schulten Sells $569K of Stock

Andre Schulten, CFO, sold 3,914 shares of Procter & Gamble Co at $145.34 a share, worth $569K in total on Oct 5, 2026. Shares held after the trade: 65,618 (-5.6%).

Value
$569K
Shares
3,914
Price
$145.34
Role
CFO
Holding change
-5.6%
Trade date
Oct 5, 2026
4:21 PM ET 8-K
Financial Results Axil Brands, Inc. AXIL

Axil Brands Financial Results

Axil Brands reported Q1 fiscal 2027 net revenues of $6.1 million and net income of $0.4 million, or $0.05 per diluted share. Results were impacted by the planned transition to the XCOR II product line, which saw initial orders exceeding $3.6 million as of late September. The company also received $0.9 million in customs duty refunds and brought in strategic partners for its Reviv3 brand relaunch.

Term
Q1 2027
Earnings call
Oct 6, 2026, 5:00 PM ET

“The principal development of the quarter was the launch of XCOR II. XCOR II was announced in August, became available on September 15, and generated orders exceeding $3.6 million through September 30 across retail, distribution, and direct-to-consumer, the strongest early demand we have seen for an AXIL product. First-quarter revenue does not yet reflect that launch.”

Jeff Toghraie, Chairman and Chief Executive Officer

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.